NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Not yet recruiting · NCT07227909 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy | peripheral neuropathy | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07227909 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| Usona Institute | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |